These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17165643)

  • 41. A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement.
    Burke J; Seda G; Allen D; Knee TS
    Mil Med; 2007 Jun; 172(6):656-8. PubMed ID: 17615852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Banning ephedra: good call, poor vision.
    Gordon JS
    Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
    [No Abstract]   [Full Text] [Related]  

  • 43. Coronary thrombosis related to use of Xenadrine RFA.
    Sachdeva R; Sivasankaran S; Fishman RF; Zarich SW; McPherson CA
    Tex Heart Inst J; 2005; 32(1):74-7. PubMed ID: 15902827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Ma Huang, from dietary supplement to abuse].
    Arditti J; Bourdon JH; Spadari M; de Haro L; Richard N; Valli M
    Acta Clin Belg; 2002; 57 Suppl 1():34-6. PubMed ID: 11974441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A rapid liquid chromatography electrospray ionization mass spectrometry(n) method for evaluation of synephrine in Citrus aurantium L. samples.
    Mattoli L; Cangi F; Maidecchi A; Ghiara C; Tubaro M; Traldi P
    J Agric Food Chem; 2005 Dec; 53(26):9860-6. PubMed ID: 16366666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.
    Preuss HG; DiFerdinando D; Bagchi M; Bagchi D
    J Med; 2002; 33(1-4):247-64. PubMed ID: 12939122
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exercise-induced syncope associated with QT prolongation and ephedra-free Xenadrine.
    Nasir JM; Durning SJ; Ferguson M; Barold HS; Haigney MC
    Mayo Clin Proc; 2004 Aug; 79(8):1059-62. PubMed ID: 15301335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of flavonoid phytoestrogens in botanical and ephedra-containing dietary supplements.
    Grippo AA; Capps K; Rougeau B; Gurley BJ
    Ann Pharmacother; 2007 Sep; 41(9):1375-82. PubMed ID: 17698891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Common dietary supplements for weight loss.
    Saper RB; Eisenberg DM; Phillips RS
    Am Fam Physician; 2004 Nov; 70(9):1731-8. PubMed ID: 15554492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural-born killers.
    Mandavilli A
    Nat Med; 2003 Jun; 9(6):634-5. PubMed ID: 12778149
    [No Abstract]   [Full Text] [Related]  

  • 51. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
    Maglione M; Miotto K; Iguchi M; Jungvig L; Morton SC; Shekelle PG
    Am J Psychiatry; 2005 Jan; 162(1):189-91. PubMed ID: 15625222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of ephedra-free labeled dietary supplements sold in the San Francisco Bay area in 2003.
    Tam JW; Dennehy CE; Ko R; Tsourounis C
    J Herb Pharmacother; 2006; 6(2):1-19. PubMed ID: 17182481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of ephedra and high fat dieting: a cause for concern! A case report.
    Fleming RM
    Angiology; 2007; 58(1):102-5. PubMed ID: 17351165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Public health officials caution against ephedra use. Health officials caution consumers against using dietary supplements containing ephedra. The stimulant can have dangerous effects on the nervous system and heart.
    Meadows M
    FDA Consum; 2003; 37(3):8-9. PubMed ID: 12793385
    [No Abstract]   [Full Text] [Related]  

  • 55. [Acute poisoning with weight-loss dietary supplement falsely suggesting the use of amphetamine].
    Łukasik-Głebocka M; Sommerfeld K; Tezyk A; Zielińska-Psuja B
    Przegl Lek; 2013; 70(10):880-3. PubMed ID: 24501816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ephedra in perspective--a current review.
    Abourashed EA; El-Alfy AT; Khan IA; Walker L
    Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature.
    Thomas JE; Munir JA; McIntyre PZ; Ferguson MA
    Tex Heart Inst J; 2009; 36(6):586-90. PubMed ID: 20069086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ephedra ban: no shortage of reasons.
    Rados C
    FDA Consum; 2004; 38(2):6-7. PubMed ID: 15101356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Ephedrine and ephedra in weight loss products and other preparations].
    van der Hooft CS; Stricker BH
    Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case of acute psychosis from herbal supplements.
    Peterson E; Stoebner A; Weatherill J; Kutscher E
    S D Med; 2008 May; 61(5):173-7. PubMed ID: 18630028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.